| 5OOH | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | 9ZZ, GOL, NAP | enzyme |
| ||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | In silico and crystallographic studies identify key structural features of biliverdin IXbeta reductase inhibitors having nanomolar potency., Nesbitt NM, Zheng X, Li Z, Manso JA, Yen WY, Malone LE, Ripoll-Rozada J, Pereira PJB, Mantle TJ, Wang J, Bahou WF, J Biol Chem. 2018 Feb 27. pii: RA118.001803. doi: 10.1074/jbc.RA118.001803. PMID:29487133 | ||||||||||||||
| Data retrieval |
![]() |
| View 5OOH in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |